http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2018010535-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
filingDate 2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7719f4b126c4199eab5b33c13c55626f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56b29c06342d73d7d06eac324e24c50d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a6810196c72b6a34f93038080e1667
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6dc3adfef83d0b3966557a3b69ff483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22debfea20ce956a3f2fd3f98825de76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96cd1071b5b59e1babf576d8991f50d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_945dd82db3461460afb51c1a6b687411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e276de950239bb51f312d25e8e66e372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f3c0c57d1b6d6c93092545062643a43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88b9a49e0fbf3dab19f57824399b1c1c
publicationDate 2019-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2018010535-A
titleOfInvention DERIVED FROM 5-METHYL-6-PHENYL-4,5-DIHIDRO-2H-PIRIDAZIN-3-ONA.
abstract The present invention provides an agent for treating a malignant tumor, comprising a compound of formula (1): (see formula I) where R 1 to R 4 are a hydrogen atom, halogen or etc., and is an optionally substituted alkylene group or etc.
priorityDate 2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409761613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13136142

Total number of triples: 30.